Benjamin J. Moeller, MD, PhD

Benjamin J. Moeller, MD, PhD

workRadiation Oncologist
location_onAtrium Health – Levine Cancer Institute – NorthEast Radiation Therapy Center

About Dr. Moeller

Radiation therapy, like many facets of cancer care, has made tremendous advances in recent years, allowing us to provide unprecedented rates of cure while minimizing side effects for our patients. The opportunities to save lives and relieve suffering in my field has never been as great as they are now, making this truly an exciting and rewarding time to be a radiation oncologist. When not working, I can usually be found helping my wife raise our 4 young children. In the (ever so infrequent) moments not with my kids, I enjoy running and reading.

"I am thankful for every day that I have the honor of serving my patients as they battle cancer; I am truly blessed to have this as my calling."

Dr. Moeller

Awards & Affiliations


Education

M. D. Anderson Cancer Center

2007 — 2011

Houston, Texas

Residency in Radiation Oncology

The University of Texas, Houston

2006 — 2007

Houston, Texas

Internship, Department of Medicine

Duke University School of Medicine

1999 — 2006

Chapel Hill, North Carolina

M.D., Ph.D., Department of Pathology

Massachusetts Institute of Technology

1995 — 1999

Cambridge, Massachusetts

Bachelor of Science., Biology and Philosophy


Employment

SERO

Charlotte, North Carolina


Publications

Find Dr. Moeller’s full list of publications on PubMed here.


Selected Meeting Presentations

  • Moeller BJ, Dreher MR, Schroeder T, Rabbani ZN, Cao Y, Dewhirst MW. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Radiation Research Society, 2005.
  • Moeller BJ, Cao Y, Li CY, Dewhirst MW. The role of free radicals and stress granules in radiation-induced HIF-1 activation. American Society for Therapeutic Radiology and Oncology, 2003.
  • Moeller BJ, Batinic-Haberle I, Spasojevic I, Rabbani ZN, Anscher MS, Vujaskovic Z, Dewhirst MW. A Superoxide Dismutase mimetic inhibits tumor growth and vascularity. Tumor Microenvironment Workshop, 2003.
  • Moeller BJ and Dewhirst MW. Developing new targets: lessons learned from HIF-1. Invited talk. International Congress of Radiation Research, 2007.
  • Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Schwartz DL. FDG-PET/CT Imaging Does Not Impact Post-Radiation Response Assessment For Advanced Head And Neck Cancer. 7th International Conference on Head and Neck Cancer, 2008.
  • Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Schwartz DL. Does FDG-PET/CT Provide Added Value Over CT Alone for Assessment of Radiation Response in
    Advanced Stage Head and Neck Cancer? American Society for Therapeutic Radiology and Oncology, 2008.
  • Moeller BJ, Cannon BA, Ang KK, Ginsberg LE, Macapinlac HA, Garden AS, Morrison WH, Rosenthal DI, Schwartz DL. Correlating Survival with Radiographic Response to Radiotherapy for Head-and-Neck Cancer Patients: FDG-PET/CT is not Superior to CT Alone. American Society for Therapeutic Radiology and Oncology, 2009.
  • Moeller BJ, Chintagumpala M, Philip JJ, Woo SY, Wolff JE, Mahajan A. Proton Radiotherapy for Pediatric Medulloblastoma: Improved Early Ototoxicity. American Society for Therapeutic Radiology and Oncology, 2010.